Abstract

Superficial vein thrombosis is an integral part of venous thromboembolism (VTE) together with deep vein thrombosis (DVT) and pulmonary embolism (PE). The incidence of SVT is 1.6 per 1000 persons per year. The incidence of DVT is about 1.0 per 1000 persons per year in the general population, 1.8 per 1000 persons per year at age 65 to 69 years and 3.1 per 1000 persons per year at age 85 to 89 years. First episodes of DVT are in two-thirds of cases elicited by risk factors, including varicose veins, cancer, pregnancy/ postpartum, oral contraceptives below the age of 50 years, immobility or surgery. Pain and tenderness in the calf and popliteal fossa may occur resulting from other conditions labeled as alternative diagnosis (AD) including Baker’s cyst, ruptured Baker’s cyst, torn plantaris tendon, hematoma, or muscle tears or pulls. The requirement for a safe diagnostic strategy of deep vein thrombosis (DVT) should be based on an objective post-test incidence of venous thromboembolism (VTE) of less than 0.1% with a negative predictive value for exclusion of DVT of 99.99% during 3 months follow-up. Modification of the Wells score by elimination of the “minus 2 points” for AD is mandatory and will improve clinical score assessment for DVT suspicion in the primary care and outpatient medical diagnostic setting. Compression ultrasonography (CUS) for proximal DVT overlooks distal DVT and is not cost-effective enough to rule in or out DVT. Complete CUS (CCUS) does pick up alternative diagnoses (AD) like Bakers cyst, muscle hematomas, old DVT, and superficial vein thrombosis (SVT). ADs with a negative CCUS include leg edema, varices erysipelas are easily picked up by physical examination. The sequential use of CCUS followed by quantitative rapid ELISA-D-dimer testing and modified Wells’ clinical score assessment is cost-effective and objective diagnostic algorithm that can safely and effectively exclude and diagnose both DVT and AD in patients with suspected DVT. About 10 to 30% of patients with DVT develop overt PTS (CEAP, C4,5) at one year post-DVT. DVT has a recurrence rate of about 20% to 30% after 5 years. A scoring system for lower extremity venous thrombosis (LET) extension on CCUS related to therapeutic implications is presented to prevent DVT recurrence and the post-thrombotic syndrome (PTS).

Highlights

  • Superficial vein thrombosis is an integral part of venous thromboembolism (VTE) together with deep vein thrombosis (DVT) and pulmonary embolism (PE)

  • In a systematic review of patients with superficial vein thrombosis (SVT), 6% to 44% of cases was associated with deep vein thrombosis (DVT), 20% to 33% with asymptomatic pulmonary embolism (PE) and 2% to 13% with symptomatic PE

  • We conclude that thrombophilia screening is manadatory in SVT and DVT patients and in women on contraceptive pills in particular for the education of clinicians abling them to much better counsel their SVT and DVT patients and their relatives

Read more

Summary

Prevalence in general population Prevalence in population with VTE RR

DVT has an annual incidence of 0.2% in the urban population [1]. The disease is rare in children under 15 year of age, but its frequency increases with age, with an incidence of about 1.0 per 1000 persons per year in the general population, 1.8 per 1000 persons per year at age 65 to 69 years and 3.1 per 1000 persons per year at age 85 to 89 years [2,3]. A number of other hereditary thrombophilia factors and acquired thrombophilic conditions and elevated FVIII predispose to venous thrombosis (Figure 1 and Table 1) [12,13,14,15]. These include protein C and S (PC, PS) deficiency, antithrombin (AT) deficiency, activated protein C resistance (which is usually associated with Factor V Leiden genetic abnormality) factor II G20210A mutation and lupus anticoagulant [2,3,13,14,15]. Prolonged immobility as in long-haul flights and hormonal influences, such as the contraceptive pill, are well-documented risk factors [9,20,21]

Clinical features
Differential diagnosis
Thrombophilia and Oral Contraceptives
Total Rotterdam DVT score
Clinical score
Negative DD No DVT
ELISA VIDAS
Management of DVT in the Primary Care and Hospital Setting
Standard Anticoagulant Treatment of DVT
Findings
Series Proximal DUS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call